CYP7B1 and metabolic dysfunction-associated steatotic liver disease: Consistent with our observations, Ma et al. (2017) reported that UDCA supplementation increased CYP7B1 mRNA levels and improved fasting glucose levels and hepatic steatosis in a diet-induced NAFLD model mouse.